Figure 10.
RPMI 8226 cells’ migration/invasion after Hib-ester and Hib-carbaldehyde treatment. Migration/invasion ability of RPMI 8226 cells was assessed by Boyden chamber assay. (A) Cells were treated with Hib-ester (3 µg/mL–1 mg/mL). (B) Cells were treated with Hib-carbaldehyde (3 µg/mL–1 mg/mL). Data represent the percentage of migrating cells with respect to CTRL, arbitrarily set to 100%, and are expressed as mean ± SD of three independent experiments. (** p < 0.01 vs. CTRL pos).